Career Feature in 2025

This pioneer in programmable biology creates new methods for the computer science and bioengineering communities and translates those advances to try to solve some of the most fundamental problems facing our world.

The right AI workflow can help you to read more widely and think more deeply — without sacrificing rigor.

The New York University Biomedical Entrepreneurship Educational Program’s career development awards boost early-stage scientists’ business knowledge and acumen to ease their transition from academia to industry.

LeDNA is a low-cost, open access tool ready to be deployed around the globe to democratize education in genetics and CRISPR gene editing technology.

A virtual course provides an opportunity for early-career researchers to witness the translation of basic and preclinical research to inform clinical decisions related to precision oncology.

Breaking the cycle of institutional betrayal and the culture of silence requires decisive actions to promote transparency, accountability and supportive environments in both academia and industry.

An innovator of new genome editing technologies on the similarities between science and cooking, and the challenge of turning a new technology into a viable business.

Women are still underrepresented in executive roles in French biotech startups, while outperforming men in merger and acquisition activities.

A strong pitch deck can help make a good first impression, establish credibility and build the confidence to secure the support and financial resources needed for eventual commercial success.

To those considering a change in careers from academia to the pharmaceutical industry, here are the keys to a successful transition.

Building undergraduate courses around biotechnology ventures integrates real-world science, business, career preparation and creative thinking for STEM student preparation.

This developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care.

SPARK Taiwan has strengthened the country’s biotech sector, encouraged scientists to start businesses and fostered cross-disciplinary collaboration.

A semiannual snapshot of job expansions, reductions and availability in the biotech and pharma sectors.

An innovative challenge-based and research-driven educational model immerses groups of undergraduate students in the discovery stages of biotech industry research.

A biophysicist interested in understanding the molecular principles of membrane protein folding and applying them to protein design discusses her nonlinear academic path and the potential societal impact of her research.

Academic medical centers must play a crucial part in overcoming cell and gene therapy development hurdles by establishing institutional frameworks that offer comprehensive support extending beyond financial assistance.